Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Fenoll, I. Jado, D. Vicioso, S. Berrón, J.E. Yuste, J. Casal.
Streptococcus pneumoniae in children in Spain: 1990-1999.
Acta Pediatr, 89 (2000), pp. 43-50
[2.]
J. Oteo, S. Cruchaga, J. Campos, J. Sáez-nieto.
Baquero F y miembros españoles del Grupo del European Antimicrobial Resístanse Surveillance System (ERAS).
Enferm Infecc Microbiol Clin, 21 (2003), pp. 12-19
[3.]
A. Casado, C. García Calvo, A. Pérez, M. Rodríguez Créixems.
Incidencia de las infecciones neumocócicas pediátricas en España. Revisión bibliográfica.
An Esp Pediatr, 57 (2002), pp. 7-13
[4.]
J. Casado Flores, A. Fenoll, J. Aristegui, C. Rodrigo, J.M. Martinón, S. Berrón, et al.
Meningitis neumocócica en niños españoles: incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico.
An Esp Pediatr, 57 (2002), pp. 295-300
[5.]
D.S. Fedson, D.M. Musher, J. Eskola.
Pneumococcal vaccine.
Vaccines, 3th ed, pp. 553-607
[6.]
M.A. Mufson, D. Hughey, E. Lydick.
Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine.
J Infect Dis, 151 (1985), pp. 749-750
[7.]
U. Samkilampi, P.O. Honkanen, A. Bloigu, E. Herva, M. Leinonen.
Antibody response to pneumococcal capsula polisaccharide vaccine in the elderly.
J Infect Dis, 173 (1996), pp. 387-393
[8.]
F. Sánchez, G. Prats, X. Garau, L. Salleras.
Vacuna antineumocócica.
Vacunaciones preventivas. Principios y aplicaciones, pp. 259-286
[9.]
Centers for Disease Control and Prevention.
Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Mmwr, 49 (2000), pp. 1-35
[10.]
S. Pelton, J. Klein.
The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children.
Pediatrics, 110 (2002), pp. 805-814
[11.]
F. De Juan.
Impacto de la inmunización frente a las enfermedades invasoras por neumococo: vacuna neumocócica conjugada.
An Esp Pediatr, 57 (2002), pp. 24-30
[12.]
H.R. Shinefield, S. Black, P. Ray, I.H. Chang, N. Lewis, B. Fireman, et al.
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
Pediatr Infect Dis J, (1999), pp. 757-763
[13.]
S.h. Choo, Q. Zhang, L. Seymour, S. Akhtar, A. Finn.
Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.
J Infect Dis, 182 (2000), pp. 1260-1263
[14.]
S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, J.R. Hansen, et al.
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.
Pediatr Infect Dis J, 19 (2000), pp. 187-195
[15.]
B. Fireman, S. Black, H. Shinefield, J. Lee, E. Lewis, P. Ray.
Impact of the pneumococcal conjugate vaccine on otitis media.
Pediatr Infect Dis J, 22 (2003), pp. 10-16
[16.]
J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, et al.
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
N Engl J Med, 344 (2001), pp. 403-409
[17.]
S. Black, H. Shinefield, S. Ling, B. Hansen JR Fireman, D. Spring, et al.
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevención of pneumonía.
Pediatr Infect Dis J, 21 (2002), pp. 810-815
[18.]
R. Dagan, N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, J. Janco, et al.
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
J Infect Dis, 185 (2002), pp. 926-936
[19.]
S.B. Black, H.R. Shinefield, J. Hansen, L. Elvin, D. Laufer, F. Malinoski.
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.
Pediatr Infect Dis J, 20 (2001), pp. 1105-1107
[20.]
H. Shinefield.
Prevention of pneumococcal disease postlicensure impact of conjugate pneumococcal vaccine on invasive disease.
3rd world Congress Pediat Infect Dis,
[21.]
C. Whitney.
The potencial of pneumococcal conjugate vaccines for children.
Pediatr Infect Dis J, 21 (2002), pp. 961-970
[22.]
R. Dagan, N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, J. Janco, et al.
Reductión of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
J Infect Dis, 185 (2002), pp. 926-936
[23.]
Comité Asesor de Vacunas de la Asociación Española de Pediatría.
Incidencia de la infección neumocócica invasora en niños menores de dos años. Vacuna neumocócica conjugada heptavalente.
Situación en España. An Esp Pediatr, 57 (2002), pp. 287-289
[24.]
F.A. Moraga, M. Campins, F. De Juan.
Vacuna conjugada antineumocócica heptavalente.
La enfermedad neumocócica en el niño, pp. 105-135
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados